CN105377814B - 作为甲酰基肽受体调节剂的n‑脲取代的氨基酸的衍生物 - Google Patents
作为甲酰基肽受体调节剂的n‑脲取代的氨基酸的衍生物 Download PDFInfo
- Publication number
- CN105377814B CN105377814B CN201480040132.5A CN201480040132A CN105377814B CN 105377814 B CN105377814 B CN 105377814B CN 201480040132 A CN201480040132 A CN 201480040132A CN 105377814 B CN105377814 B CN 105377814B
- Authority
- CN
- China
- Prior art keywords
- amino
- alkyl
- group
- optionally substituted
- carbamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 COC(C(C1)([C@]1c1ccccc1)NC([C@@](C*)(NC(Nc(cc1)ccc1S(C)(=O)=O)=O)S)=O)=O Chemical compound COC(C(C1)([C@]1c1ccccc1)NC([C@@](C*)(NC(Nc(cc1)ccc1S(C)(=O)=O)=O)S)=O)=O 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361846787P | 2013-07-16 | 2013-07-16 | |
| US61/846,787 | 2013-07-16 | ||
| PCT/US2014/046203 WO2015009545A1 (en) | 2013-07-16 | 2014-07-10 | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105377814A CN105377814A (zh) | 2016-03-02 |
| CN105377814B true CN105377814B (zh) | 2018-04-03 |
Family
ID=51230227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480040132.5A Expired - Fee Related CN105377814B (zh) | 2013-07-16 | 2014-07-10 | 作为甲酰基肽受体调节剂的n‑脲取代的氨基酸的衍生物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9428549B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3022174B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6653253B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102313757B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN105377814B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2014290618B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2917811C (cg-RX-API-DMAC10.html) |
| DK (1) | DK3022174T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2708571T3 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2696581C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2015009545A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE040145T2 (hu) | 2011-10-26 | 2019-02-28 | Allergan Inc | N-karbamid szubsztituált aminosavak amid származékai mint formilpeptidszerû receptor 1 (FPRL1) receptormodulátorok |
| AU2014226001B2 (en) | 2013-03-06 | 2018-12-06 | Allergan, Inc. | Use of agonists of Formyl peptide receptor 2 for treating dermatological diseases |
| BR112016011417A8 (pt) | 2013-11-21 | 2020-05-05 | Allergan Inc | derivados de fenilcarbamatos como moduladores do receptor de formil peptídeo, composição farmacêutica, e seus usos |
| EP3305763B1 (en) | 2013-11-28 | 2019-07-24 | Kyorin Pharmaceutical Co., Ltd. | Deuterated or isotopically labeled urea derivatives or pharmacologically acceptable salts thereof useful as fprl-1 agonists |
| US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
| KR20170005121A (ko) | 2014-05-21 | 2017-01-11 | 알러간, 인코포레이티드 | 폼일 펩타이드 수용체 조절제로서의 이미다졸 유도체 |
| AU2016266190A1 (en) | 2015-05-27 | 2018-01-18 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| WO2016189877A1 (en) | 2015-05-27 | 2016-12-01 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| TW201718473A (zh) * | 2015-08-05 | 2017-06-01 | 歐樂根公司 | 作為甲醯肽受體1(fpr1)選擇性促效劑之苯基脲類似物 |
| WO2019173182A1 (en) | 2018-03-05 | 2019-09-12 | Bristol-Myers Squibb Company | Phenylpyrrolidinone formyl peptide 2 receptor agonists |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0107597A1 (fr) * | 1982-09-17 | 1984-05-02 | Universite Claude Bernard - Lyon 1 | Composés chimiques et utilisation comme édulcorants |
| CN1057269A (zh) * | 1990-05-14 | 1991-12-25 | 藤泽药品工业株式会社 | 肽化合物及其制备 |
| JPH06172288A (ja) * | 1992-12-04 | 1994-06-21 | Toyama Chem Co Ltd | 新規なフェニルアラニン誘導体またはその塩 |
| WO1999065932A1 (en) * | 1998-06-18 | 1999-12-23 | Sepracor, Inc. | Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
| US20130109866A1 (en) * | 2011-10-26 | 2013-05-02 | Allergan, Inc. | Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| CN105007909A (zh) * | 2013-03-06 | 2015-10-28 | 阿勒根公司 | 用于治疗眼部炎性疾病的甲酰基肽受体2激动剂的用途 |
| CN105007908A (zh) * | 2013-03-06 | 2015-10-28 | 阿勒根公司 | 用于治疗皮肤病的甲酰基肽受体2的激动剂的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030009022A1 (en) * | 1993-03-31 | 2003-01-09 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
| PT739903E (pt) * | 1994-02-09 | 2002-05-31 | Shionogi & Co | Derivado carbamoilmetilureia |
| JP2968842B2 (ja) * | 1994-02-09 | 1999-11-02 | 塩野義製薬株式会社 | カルバモイルメチルウレア誘導体 |
| US6423689B1 (en) * | 1997-12-22 | 2002-07-23 | Warner-Lambert Company | Peptidyl calcium channel blockers |
| JP2005536187A (ja) * | 2002-04-03 | 2005-12-02 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | N−ホルミルペプチド受容体様1(fprl1)に関連する疾患の診断および治療 |
| WO2005047899A2 (en) | 2003-11-07 | 2005-05-26 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| JP5510945B2 (ja) * | 2009-05-18 | 2014-06-04 | アクテリオン ファーマシューティカルズ リミテッド | Alx受容体及び/又はfprl2アゴニストとしての架橋スピロ[2.4]ヘプタン誘導体 |
| AU2011336973A1 (en) * | 2010-12-03 | 2013-07-11 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| US8541577B2 (en) * | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| US8735622B2 (en) * | 2011-11-30 | 2014-05-27 | The Regents Of The University Of Colorado, A Body Corporate | Histone demethylase inhibitors and methods for using the same |
-
2014
- 2014-07-10 KR KR1020167003770A patent/KR102313757B1/ko not_active Expired - Fee Related
- 2014-07-10 AU AU2014290618A patent/AU2014290618B2/en not_active Ceased
- 2014-07-10 US US14/328,540 patent/US9428549B2/en active Active
- 2014-07-10 DK DK14744725.4T patent/DK3022174T3/da active
- 2014-07-10 RU RU2016104844A patent/RU2696581C2/ru active
- 2014-07-10 WO PCT/US2014/046203 patent/WO2015009545A1/en not_active Ceased
- 2014-07-10 EP EP14744725.4A patent/EP3022174B1/en active Active
- 2014-07-10 CN CN201480040132.5A patent/CN105377814B/zh not_active Expired - Fee Related
- 2014-07-10 JP JP2016526992A patent/JP6653253B2/ja not_active Expired - Fee Related
- 2014-07-10 ES ES14744725T patent/ES2708571T3/es active Active
- 2014-07-10 CA CA2917811A patent/CA2917811C/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0107597A1 (fr) * | 1982-09-17 | 1984-05-02 | Universite Claude Bernard - Lyon 1 | Composés chimiques et utilisation comme édulcorants |
| CN1057269A (zh) * | 1990-05-14 | 1991-12-25 | 藤泽药品工业株式会社 | 肽化合物及其制备 |
| JPH06172288A (ja) * | 1992-12-04 | 1994-06-21 | Toyama Chem Co Ltd | 新規なフェニルアラニン誘導体またはその塩 |
| WO1999065932A1 (en) * | 1998-06-18 | 1999-12-23 | Sepracor, Inc. | Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
| US20130109866A1 (en) * | 2011-10-26 | 2013-05-02 | Allergan, Inc. | Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| CN105007909A (zh) * | 2013-03-06 | 2015-10-28 | 阿勒根公司 | 用于治疗眼部炎性疾病的甲酰基肽受体2激动剂的用途 |
| CN105007908A (zh) * | 2013-03-06 | 2015-10-28 | 阿勒根公司 | 用于治疗皮肤病的甲酰基肽受体2的激动剂的用途 |
Non-Patent Citations (1)
| Title |
|---|
| 二肽和三肽甜味剂的结构性能关系;曾广植;《应用化学》;19901231;第7卷(第1期);1-9 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20150025021A1 (en) | 2015-01-22 |
| WO2015009545A1 (en) | 2015-01-22 |
| EP3022174B1 (en) | 2018-09-05 |
| JP6653253B2 (ja) | 2020-02-26 |
| EP3022174A1 (en) | 2016-05-25 |
| RU2016104844A (ru) | 2017-08-21 |
| CN105377814A (zh) | 2016-03-02 |
| CA2917811A1 (en) | 2015-01-22 |
| DK3022174T3 (da) | 2019-01-02 |
| US9428549B2 (en) | 2016-08-30 |
| ES2708571T3 (es) | 2019-04-10 |
| JP2016529235A (ja) | 2016-09-23 |
| CA2917811C (en) | 2021-08-31 |
| AU2014290618A1 (en) | 2016-02-18 |
| KR20160031007A (ko) | 2016-03-21 |
| AU2014290618B2 (en) | 2018-04-05 |
| RU2696581C2 (ru) | 2019-08-05 |
| KR102313757B1 (ko) | 2021-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104114164B (zh) | 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物 | |
| KR102313757B1 (ko) | 펩타이드 수용체 조절제로서의 n-우레아 치환된 아미노산의 유도체 | |
| RU2627271C2 (ru) | Производные арилмочевины в качестве модуляторов n-формилпептидного-1 рецептора (fprl-1) | |
| CN104302630A (zh) | 作为甲酰肽受体2调节剂的(2-脲基乙酰氨基)烷基衍生物 | |
| WO2015042071A1 (en) | Diphenyl urea derivatives as formyl peptide receptor modulators | |
| CN105705484A (zh) | 作为甲酰肽受体调节剂的苯基氨基甲酸酯衍生物 | |
| US9868700B2 (en) | Carbamoyl hydrazine derivatives as formyl peptide modulators | |
| HK1225012B (en) | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators | |
| HK1225012A1 (en) | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators | |
| HK1228885A (en) | Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators | |
| HK1228885A1 (en) | Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators | |
| HK1199622B (en) | Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180403 |